Press Release: Advanced Radiation Centers of New York Pioneers the First Commercial U.S. Implantation of a Biodegradable Balloon Spacer that Will Revolutionize Radiation Therapy for Prostate Cancer

Physicians at medical practices affiliated with Solaris Health, the nation’s leading healthcare management company in the urological field, are the first throughout the country to provide a new technology that substantially enhances safety for patients undergoing radiation therapy for prostate cancer.…

Empire Blue Cross/Blue Shield Reverses Course

Empire Blue Cross/Blue Shield has agreed to reverse a decision made last month to no longer cover services oncological patients receive from facilities run by Integrated Medical Professionals of Farmingdale. Its 52 locations serviced 1300 Long Islanders, including East Enders who already had to drive up the island to find a facility to receive treatment.…

Exposure to CyberKnife Advertising is Associated with Over-Estimation of Objective Benefits Compared with other Prostate Cancer Treatments

There has been increased direct-to-consumer advertising for Cyberknife (CK), a brand of stereotactic radiotherapy for prostate cancer. Evidence comparing CyberKnife with other prostate cancer therapies is limited. Columbia University Medical Center physicians hypothesized that those viewing CyberKnife advertisements would have inaccurate impressions regarding its effectiveness and safety.…